Company news

Simulations Plus, Inc. news in 2025

Simulations Plus, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development

December 18, 2025

Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

December 17, 2025

Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions

December 9, 2025

Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

December 1, 2025

Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

October 22, 2025

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design

July 29, 2025

Simulations Plus Invests in Clinical Development Technology Company Nurocor

July 14, 2025

Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results

July 14, 2025

Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call

June 18, 2025

Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum

June 12, 2025

Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

June 11, 2025

Simulations Plus Releases ADMET Predictor® 13

June 5, 2025

Simulations Plus Releases DILIsym® 11

May 15, 2025

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

April 21, 2025

Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

April 3, 2025

Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date

March 20, 2025

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum

March 10, 2025

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements

January 21, 2025

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

January 12, 2025

Simulations Plus Reports First Quarter Fiscal 2025 Financial Results

January 6, 2025

Calls in 2025

Decks in 2025